Avanos Medical, Inc. has gone through a transition period recently and its stock appears cheap with a low P/E ratio. The company has limited analyst firm coverage but has done a commendable job ...

It has been about a month since the last earnings report for Avanos Medical (AVNS). Shares have lost about 5.8% in that time frame, underperforming the S&P 500. Will the recent negative trend ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Catalyst Pharma (CPRX – Research Report), ...

Investing.com — 周一，Stifel分析师维持对Avanos Medical（NYSE:AVNS）股票的持有评级，目标价为17.00美元。该股目前交易价格为12.43美元，接近其52周低点11.90美元，过去六个月下跌了45.65%。根据InvestingPro分析，基于其综合公允价值模型，该公司目前被低估。 Avanos Medical是 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Avanos Medical, Inc. (NYSE:AVNS), a leading provider of medical devices and supplies with a market capitalization of $572 million, has announced significant changes in its executive team ...